Your browser doesn't support javascript.
loading
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer.
Sethunath, Vidyalakshmi; Hu, Huizhong; De Angelis, Carmine; Veeraraghavan, Jamunarani; Qin, Lanfang; Wang, Nicholas; Simon, Lukas M; Wang, Tao; Fu, Xiaoyong; Nardone, Agostina; Pereira, Resel; Nanda, Sarmistha; Griffith, Obi L; Tsimelzon, Anna; Shaw, Chad; Chamness, Gary C; Reis-Filho, Jorge S; Weigelt, Britta; Heiser, Laura M; Hilsenbeck, Susan G; Huang, Shixia; Rimawi, Mothaffar F; Gray, Joe W; Osborne, C Kent; Schiff, Rachel.
Affiliation
  • Sethunath V; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Hu H; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • De Angelis C; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas.
  • Veeraraghavan J; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Qin L; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Wang N; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Simon LM; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Wang T; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Fu X; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Nardone A; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Pereira R; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Nanda S; Department of Biomedical Engineering and OHSU Center for Spatial Systems Biomedicine, Portland, Oregon.
  • Griffith OL; Institute of Computational Biology, Helmholtz Zentrum München, Neuherberg, Germany.
  • Tsimelzon A; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Shaw C; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Chamness GC; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Reis-Filho JS; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Weigelt B; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Heiser LM; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Hilsenbeck SG; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Huang S; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Rimawi MF; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Gray JW; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, Missouri.
  • Osborne CK; Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.
  • Schiff R; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
Mol Cancer Res ; 17(11): 2318-2330, 2019 11.
Article in En | MEDLINE | ID: mdl-31420371
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Signal Transduction / Receptor, ErbB-2 / Drug Resistance, Neoplasm / Mevalonic Acid / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Signal Transduction / Receptor, ErbB-2 / Drug Resistance, Neoplasm / Mevalonic Acid / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Country of publication: